Mesoblast Mesenchymal Stem Cells (adult human)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mesoblast Mesenchymal Stem Cells (adult human), covering 2022-02-10 to 2022-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD) [Phase 3]